Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Express Scripts
McKesson
Harvard Business School
Dow

Last Updated: May 25, 2022

CLINICAL TRIALS PROFILE FOR MELOXICAM


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Meloxicam

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00034853 ↗ Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA) Completed Boehringer Ingelheim Phase 3 2000-12-01 To obtain safety, efficacy, pharmacokinetic and dosing information for meloxicam oral suspension in children with Juvenile Rheumatoid Arthritis (JRA)
NCT00042068 ↗ A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis Completed Boehringer Ingelheim Phase 3 2002-06-01 A 12-week trial consisting of 5 visits (6 if follow up is needed) to find out how effective and safe three different doses of meloxicam are compared with placebo in Rheumatoid Arthritis. Patient will take one dose of study medication daily.
NCT00152919 ↗ Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate Brachytherapy Completed Princess Margaret Hospital, Canada Phase 3 2004-02-01 Swelling of the prostate can occur during and after a brachytherapy. This swelling can cause urinary problems ranging from difficulty voiding to urinary retention. The purpose of this study is to investigate whether Mobicox started one week before brachytherapy and then continued afterwards is more effective in reducing the risk of needing a catheter than Mobicox given only afterwards.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Meloxicam

Condition Name

Condition Name for Meloxicam
Intervention Trials
Healthy 18
Osteoarthritis 10
Arthritis, Rheumatoid 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Meloxicam
Intervention Trials
Osteoarthritis 17
Arthritis, Rheumatoid 10
Osteoarthritis, Knee 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Meloxicam

Trials by Country

Trials by Country for Meloxicam
Location Trials
United States 199
Japan 20
China 15
Brazil 12
Canada 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Meloxicam
Location Trials
Massachusetts 11
Texas 10
Pennsylvania 10
Florida 10
California 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Meloxicam

Clinical Trial Phase

Clinical Trial Phase for Meloxicam
Clinical Trial Phase Trials
Phase 4 13
Phase 3 26
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Meloxicam
Clinical Trial Phase Trials
Completed 69
Unknown status 5
Recruiting 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Meloxicam

Sponsor Name

Sponsor Name for Meloxicam
Sponsor Trials
Boehringer Ingelheim 29
Iroko Pharmaceuticals, LLC 3
Axsome Therapeutics, Inc. 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Meloxicam
Sponsor Trials
Industry 59
Other 44
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Boehringer Ingelheim
Mallinckrodt
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.